Stockreport

Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses [Yahoo! Finance]

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF R&D Expenses: $93.6 million in Q4 2024, compared to $85 million in Q4 2023. Full Year R&D Expenses: $339.4 million in 2024, compared to $330.1 million in 2023. G&A [Read more]